Evidence map›Paper›PMID 41695519›Full record

ReviewHeart rhythm O22026

Cardiac lead perforation: Mechanisms, detection, and therapeutic approaches.

Ameer Awashra, Mohammed AbuBaha, Hossam Salameh, Hammam Jallad, Aya Milhem, Anwar Zahran, Aseel Badwan, Fathi Milhem, Abdalhakim Shubietah

Abstract readReview
In one paragraph

Review in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Active versus passive fixation leads in cardiac implantable devices: a meta-analysis of post-discharge cardiac perforation and lead dislodgement risk.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ameer AwashraDepartment of Medicine, An Najah National University, Nablus, Palestine.
Mohammed AbuBahaDepartment of Medicine, An Najah National University, Nablus, Palestine.
Hossam SalamehDepartment of Medicine, An Najah National University, Nablus, Palestine.
Hammam JalladDepartment of Medicine, An Najah National University, Nablus, Palestine.
Aya MilhemDepartment of Medicine, An Najah National University, Nablus, Palestine.
Anwar ZahranDepartment of Medicine, An Najah National University, Nablus, Palestine.
Aseel BadwanSchool of Medicine, The University of Jordan, Amman, Jordan.
Fathi MilhemDepartment of Medicine, An Najah National University, Nablus, Palestine.
Abdalhakim ShubietahDepartment of Medicine, Advocate Illinois Masonic Medical Center, Illinois.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac lead perforation is an infrequent but serious complication of cardiac implantable electronic devices, with possibly lethal consequences if left untreated. Because of its very varied clinical appearance and lack of established criteria, perforation still presents diagnostic and therapeutic hurdles despite continuous improvements in lead design and insertion procedures. This review summarizes current research on the processes, risk factors, and clinical range of lead perforation. Thin myocardial walls, especially at the right ventricular apex; active-fixation leads; and operator-dependent elements, such as lead placement and torque, are important anatomic and procedural contributions. Steroid usage, low body mass index, and female sex all increase risk. A strong index of suspicion is often required for prompt diagnosis because presentations vary from asymptomatic instances to severe tamponade. Device interrogation must be integrated with imaging modalities, particularly computed tomography and echocardiography, which each have unique benefits based on the clinical setting, to achieve accurate detection. From cautious observation in stable patients to immediate percutaneous or surgical intervention in unstable or worsening situations, management approaches are highly customized. New technologies, including subcutaneous implantable cardioverter-defibrillators and leadless pacemakers, have the potential to lower the incidence of perforations, but they also present new difficulties that need to be further investigated. Importantly, the lack of consistent diagnostic standards hinders study/ comparability and postpones the creation of guidelines. Standardizing diagnostic criteria, establishing multicenter prospective registries, developing machine learning-based risk stratification tools, and conducting clinical trials to inform the treatment of asymptomatic or delayed perforations are among the top goals for the future. To improve patient outcomes and advance clinical practice, international cooperation and uniform reporting standards are crucial.

Indexed as

Cardiac lead perforationDevice-related complicationsLead dislodgementLead extractionPacemaker lead perforationSurgical revisionTransvenous pacing

Identifiers

PMID41695519
PMCPMC12902149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.